Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.0K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K
Vaccinations01:51

Vaccinations

51.5K
Overview
51.5K
Emerging Adulthood01:27

Emerging Adulthood

663
Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
663
Self-Efficacy01:29

Self-Efficacy

219
Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
219
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

327
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
327
Applications of GIS: Disaster Management and Emergency Response01:29

Applications of GIS: Disaster Management and Emergency Response

503
Geographic Information System (GIS) technology is essential for risk identification, action prioritization, and resource optimization in critical situations like flooding and earthquakes. By integrating spatial and demographic data, GIS provides a comprehensive framework for emergency response.GIS integrates data layers, like rainfall intensity, topography, elevation profiles, and river levels, to model high-risk flood zones. These layers assess areas susceptible to flooding based on their...
503

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy design.

ArXiv·2026
Same author

Immune Checkpoint Therapy Drives Maturation of a Cellular Neighborhood Nucleated by T Cell-APC Triads Enabling Spatially Compartmentalized Tumor Immunity.

bioRxiv : the preprint server for biology·2026
Same author

mRNA vaccines engage unconventional pathways in CD8<sup>+</sup> T cell priming.

Nature·2026
Same author

STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition.

Molecular cancer therapeutics·2024
Same author

Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.

Genome medicine·2024
Same author

Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy.

Nature·2024
Same journal

Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis.

Annual review of medicine·2026
Same journal

CAR T Cell Toxicities and Emerging Treatment Strategies.

Annual review of medicine·2026
Same journal

Transthyretin Amyloid Cardiomyopathy: A Rapidly Evolving Landscape.

Annual review of medicine·2026
Same journal

Accessibility of Somatic Genetic Testing for Cancer Treatment Decisions.

Annual review of medicine·2026
Same journal

Diffuse Parenchymal Lung Disease: Updates in Pathophysiology and Management.

Annual review of medicine·2026
Same journal

Revascularization for Ischemic Cardiomyopathy: Disproving the 45-Year-Old Concept of Hibernating Myocardium.

Annual review of medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 29, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.0K

Cancer Neoantigen Vaccines Emerge Efficacious.

Hussein Sultan1,2, Robert D Schreiber1,2,3

  • 1Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA;

Annual Review of Medicine
|January 27, 2026
PubMed
Summary
This summary is machine-generated.

Cancer vaccines targeting tumor neoantigens show promise. Immunogenomics identifies these targets, enabling personalized cancer therapies with potential for broader application in patients.

Keywords:
cancer vaccinesdark matter antigensimmune editingsuppressive cellstumor neoantigens

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.2K
A Method to Test the Efficacy of Handwashing for the Removal of Emerging Infectious Pathogens
09:02

A Method to Test the Efficacy of Handwashing for the Removal of Emerging Infectious Pathogens

Published on: June 7, 2017

19.7K

Related Experiment Videos

Last Updated: Jan 29, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.0K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.2K
A Method to Test the Efficacy of Handwashing for the Removal of Emerging Infectious Pathogens
09:02

A Method to Test the Efficacy of Handwashing for the Removal of Emerging Infectious Pathogens

Published on: June 7, 2017

19.7K

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • The immune system plays a critical role in cancer development and treatment.
  • Advances in technology have deepened our understanding of immune system function in cancer.

Purpose of the Study:

  • To review the discovery and application of tumor-specific neoantigens.
  • To summarize preclinical and clinical evidence for neoantigen cancer vaccines.
  • To discuss challenges and future directions for neoantigen-based cancer therapies.

Main Methods:

  • Utilizing immunogenomics, next-generation sequencing, and predictive algorithms to identify tumor-specific mutant proteins (neoantigens).
  • Evaluating the efficacy of personalized cancer vaccines based on these neoantigens in preclinical models and human patients.

Main Results:

  • Somatic mutation-based tumor neoantigens are effective targets for immunotherapy.
  • Personalized cancer vaccines targeting neoantigens have demonstrated efficacy in preclinical and clinical studies.
  • Neoantigen identification and vaccine development are advancing personalized cancer treatment.

Conclusions:

  • Tumor-specific neoantigens are crucial for developing effective cancer immunotherapies.
  • Personalized cancer vaccines show significant therapeutic potential.
  • Ongoing research aims to improve the generalizability and efficacy of neoantigen-based therapies for a wider patient population.